Abstract | PURPOSE: The aim of this study was to evaluate disease-free survival (DFS), overall survival and toxicity of patients who underwent preoperative therapy for soft tissue sarcoma. MATERIALS AND METHODS: RESULTS: Median follow-up was 4.9 years (range 1-13.7 years). All patients received preoperative external beam radiotherapy (RT). Most patients (84.2 %) underwent neoadjuvant chemotherapy treatment associated with radiotherapy. After neoadjuvant treatment, the majority of patients underwent wide excision (32 out of 38) and five patients had marginal surgery; only one patient underwent amputation. Local recurrence was observed in only two patients (5.2 %). Fourteen (36.8 %) patients experienced metastatic relapse. At the time of our analysis 13 patients (34.2 %) had died due to metastatic spread of the disease. In our series, DFS in relation to distant metastases (DM) showed a significant result for lower limb involvement (p = 0.038) and marginal excision (p = 0.024), both predictors of a worse DFS, histology was statistically significant although it was not possible to evaluate the risk for specific histology due to the small number of events in the different subtypes. CONCLUSIONS: The results obtained from our study are encouraging with regard to the feasibility and efficacy of preoperative RT in the treatment of soft tissue sarcoma in view of the results obtained in terms of local control, limb sparing and safety.
|
Authors | Daniela Greto, Lorenzo Livi, Calogero Saieva, Pierluigi Bonomo, Icro Meattini, Mauro Loi, Lucia Di Brina, Giovanni Beltrami, Domenico Campanacci, Guido Scoccianti, Rodolfo Capanna, Monica Mangoni, Fabiola Paiar, Alessandro Franchi, Giampaolo Biti |
Journal | La Radiologia medica
(Radiol Med)
Vol. 119
Issue 3
Pg. 195-200
(Mar 2014)
ISSN: 1826-6983 [Electronic] Italy |
PMID | 24277509
(Publication Type: Journal Article)
|
Topics |
- Adult
- Aged
- Diagnostic Imaging
- Disease-Free Survival
- Female
- Humans
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Radiotherapy, Adjuvant
- Retrospective Studies
- Sarcoma
(drug therapy, pathology, radiotherapy)
- Soft Tissue Neoplasms
(drug therapy, pathology, radiotherapy)
|